1. Home
  2. URGN vs CRON Comparison

URGN vs CRON Comparison

Compare URGN & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$25.73

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Cronos Group Inc.

CRON

Cronos Group Inc.

HOLD

Current Price

$2.82

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
URGN
CRON
Founded
2004
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
URGN
CRON
Price
$25.73
$2.82
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$29.29
N/A
AVG Volume (30 Days)
704.1K
933.6K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,128,000.00
$146,587,000.00
Revenue This Year
$129.09
$26.34
Revenue Next Year
$70.96
$15.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.63
52 Week Low
$3.42
$1.78
52 Week High
$30.00
$3.43

Technical Indicators

Market Signals
Indicator
URGN
CRON
Relative Strength Index (RSI) 75.81 65.49
Support Level $18.55 $2.45
Resistance Level $30.00 $3.43
Average True Range (ATR) 1.42 0.12
MACD 0.74 0.03
Stochastic Oscillator 82.27 43.13

Price Performance

Historical Comparison
URGN
CRON

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

About CRON Cronos Group Inc.

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Share on Social Networks: